HomeInsightsStock Comparison

Divis Laboratories Ltd vs Laurus Labs Ltd Stock Comparison

Divis Laboratories Ltd vs Laurus Labs Ltd Stock Comparison

Last Updated on: Sep 21, 2025

Key Highlights

  • The Latest Trading Price of Divis Laboratories Ltd is ₹ 6198 as of 19 Sep 15:30.
  • The P/E Ratio of Divis Laboratories Ltd changed from 38.3 on March 2020 to 69.8 on March 2025 . This represents a CAGR of 10.52% over 6 yearsThe P/E Ratio of Laurus Labs Ltd changed from 13.5 on March 2020 to 92.4 on March 2025 . This represents a CAGR of 37.79% over 6 years.
  • The Market Cap of Divis Laboratories Ltd changed from ₹ 52763 crore on March 2020 to ₹ 153257 crore on March 2025 . This represents a CAGR of 19.45% over 6 yearsThe Market Cap of Laurus Labs Ltd changed from ₹ 3449 crore on March 2020 to ₹ 33099 crore on March 2025 . This represents a CAGR of 45.78% over 6 years.
  • The revenue of Divis Laboratories Ltd for the Jun '25 is ₹ 2529 crore as compare to the Mar '25 revenue of ₹ 2671 crore. This represent the decline of -5.32% The revenue of Laurus Labs Ltd for the Jun '25 is ₹ 1580 crore as compare to the Mar '25 revenue of ₹ 1778 crore. This represent the decline of -11.18%.
  • The ebitda of Divis Laboratories Ltd for the Jun '25 is ₹ 848 crore as compare to the Mar '25 ebitda of ₹ 972 crore. This represent the decline of -12.76% The ebitda of Laurus Labs Ltd for the Jun '25 is ₹ 392.56 crore as compare to the Mar '25 ebitda of ₹ 479.17 crore. This represent the decline of -18.08%.
  • The net profit of Divis Laboratories Ltd changed from ₹ 356 crore to ₹ 545 crore over 9 quarters. This represents a CAGR of 20.84% The net profit of Laurus Labs Ltd changed from ₹ 28.4 crore to ₹ 161.08 crore over 9 quarters. This represents a CAGR of 116.27% .
  • The Dividend Payout of Divis Laboratories Ltd changed from 33.04 % on March 2020 to 0 % on March 2025 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Laurus Labs Ltd changed from 10.13 % on March 2020 to 17.01 % on March 2025 . This represents a CAGR of 9.02% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Divis Laboratories Ltd

  • Divi's Laboratories Limited is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals.
  • The Company is one of the world's largest API companies, with two manufacturing units and a market presence across 100 countries.
  • It is engaged in the manufacture of Active Pharmaceutical ingredients (API's), Intermediates and Nutraceutical ingredients with predominance in exports.
  • In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management.
  • It is among the largest pharmaceutical companies in India with a portfolio of approx.

About Laurus Labs Ltd

  • Laurus Labs Limited was originally incorporated as 'Laurus Labs Private Limited' on September 19, 2005 at Hyderabad, Andhra Pradesh, India as a private limited company.
  • The company was subsequently converted into a public limited company and its name was changed to Laurus Labs Limited on February 12, 2007.
  • Subsequently the name of the company was changed to Aptuit Laurus Limited consequent to the strategic partnership entered into by the company with Aptuit Singapore on July 19, 2007.
  • Thereafter the company was converted into a private limited company and its name was changed to Aptuit Laurus Private Limited on July 24, 2007.
  • Subsequently, company was converted into a public limited company and the name of the company was changed to Laurus Labs Limited on August 16, 2016. Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology.

Divis Laboratories Ltd News Hub

News

Divis Laboratories Ltd up for third straight session

Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at ...

Read more

25 Aug 2025 13:05

News

Divis Lab gains as broker reiterates buy call

The brokerage downplayed concerns over Eli Lilly's oral GLP-1 candidate Orforglipron and g...

Read more

22 Aug 2025 12:40

News

Divis Lab slides after Q1 PAT falls 18% QoQ to Rs 545 cr

Revenue from operations also declined 6.79% quarter on quarter (QoQ) to Rs 2,410 crore for...

Read more

06 Aug 2025 13:34

News

Divis Laboratories to table results

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 6 Augus...

Read more

28 Jul 2025 10:49

News

Divis Laboratories Ltd up for third consecutive session

Divis Laboratories Ltd is up for a third straight session today. The stock is quoting at R...

Read more

11 Jun 2025 13:05

News

Divis Laboratories Ltd down for fifth straight session

Divis Laboratories Ltd is down for a fifth straight session today. The stock is quoting at...

Read more

02 Jun 2025 13:35

Laurus Labs Ltd News Hub

News

Laurus Labs Ltd soars 1.7%

Laurus Labs Ltd is up for a third straight session in a row. The stock is quoting at Rs 87...

Read more

03 Sep 2025 13:05

News

Volumes spurt at Laurus Labs Ltd counter

Poonawalla Fincorp Ltd, Kajaria Ceramics Ltd, Aadhar Housing Finance Ltd, SBI Life Insuran...

Read more

28 Jul 2025 11:00

News

Laurus Labs Ltd rises for third consecutive session

Laurus Labs Ltd gained for a third straight session today. The stock is quoting at Rs 893....

Read more

28 Jul 2025 13:05

News

Laurus Labs climbs on robust Q1 earnings

Gross margin improved to 59.4% in Q1 June 2025, up from 55.1% in Q1 June 2024. Profit befo...

Read more

28 Jul 2025 14:46

News

Laurus Labs to announce Quarterly Result

Laurus Labs will hold a meeting of the Board of Directors of the Company on 25 July 2025. ...

Read more

10 Jul 2025 10:29

News

Laurus Labs invests Rs 39.99 cr in Laurus Bio

Laurus Labs has invested Rs 39.99 crore and acquired 15,414 Series A2 Compulsorily Convert...

Read more

26 Jun 2025 13:24

SWOT Analysis Of Laurus Labs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Divis Laboratories Ltd

Strength

4

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Laurus Labs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Divis Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Divis Laboratories Ltd and Laurus Labs Ltd

Which company has a larger market capitalization, Divis Laboratories Ltd or Laurus Labs Ltd?

Market cap of Divis Laboratories Ltd is 164,554 Cr while Market cap of Laurus Labs Ltd is 50,298 Cr

What are the key factors driving the stock performance of Divis Laboratories Ltd and Laurus Labs Ltd?

The stock performance of Divis Laboratories Ltd and Laurus Labs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Divis Laboratories Ltd and Laurus Labs Ltd?

As of September 21, 2025, the Divis Laboratories Ltd stock price is INR ₹6198.65. On the other hand, Laurus Labs Ltd stock price is INR ₹931.75.

How do dividend payouts of Divis Laboratories Ltd and Laurus Labs Ltd compare?

To compare the dividend payouts of Divis Laboratories Ltd and Laurus Labs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions